Creating a New Cancer Therapeutic Agent by Targeting the Interaction between Bcl-2 and IP [electronic resource]
Producer: 20200929ISSN:- 1943-0264
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Bridged Bicyclo Compounds, Heterocyclic -- pharmacology
- Calcium Signaling
- Cell Death
- Cell Line, Tumor
- Cell Proliferation
- Cell Survival
- Endoplasmic Reticulum -- metabolism
- Feedback, Physiological
- Gene Expression Regulation, Neoplastic
- Humans
- Immune System
- Inositol 1,4,5-Trisphosphate Receptors -- metabolism
- Mice
- Neoplasms -- drug therapy
- Protein Domains
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- Signal Transduction
- Sulfonamides -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.